U.S. Gas Utilities Stock News

NasdaqGS:SLDP
NasdaqGS:SLDPAuto Components

Solid Power (SLDP) Valuation Check As Electrolyte Commercialization And Partnerships Progress

Solid Power (SLDP) is in focus after reporting first quarter 2026 results alongside progress on its electrolyte commercialization plans, giving you fresh numbers and project updates to weigh against the current share price. See our latest analysis for Solid Power. Solid Power’s recent earnings update, electrolyte progress with SK On and Samsung SDI, and funding raise come after a volatile period, with a 1-day share price return of negative 12.71% and a 1-year total shareholder return of very...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Why Solventum (SOLV) Is Up 6.4% After Reaffirming 2026 Outlook Despite Softer Q1 Results – And What's Next

Solventum Corporation recently reported Q1 2026 results showing revenue of US$2,007 million versus US$2,070 million a year earlier, with net income falling to US$13 million and GAAP EPS easing, even as adjusted EPS of US$1.48 and organic sales growth of 2.1% surpassed analyst expectations. Management reaffirmed full-year 2026 guidance, highlighted progress on a US$500 million cost-savings program and major R&D and manufacturing expansions, and began executing a US$1 billion share repurchase...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope Unveils AgentSkope As Investors Weigh AI Automation Prospects

Netskope (NasdaqGS:NTSK) has introduced AgentSkope, an AI-driven agentic operations platform for automating security and network workflows. The new platform brings a suite of AI-powered agents designed to handle routine and complex operational tasks for security and network teams. This launch adds a fresh product to Netskope's portfolio in automated cybersecurity operations, an area where many enterprises are seeking more efficiency. Netskope trades at $11.4, with the stock showing a 14.5%...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences (CAI) Turns Q4 Profit After US$517 Million Quarterly Loss Testing Bullish Thesis

Caris Life Sciences (CAI) closed FY 2025 with Q4 revenue of US$292.9 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$812.0 million and a trailing basic EPS loss of US$3.22, set against a 97% year over year revenue increase and expectations for earnings to grow about 70.5% per year with profitability projected within three years. Over recent periods, the company has seen quarterly revenue move from US$101.6 million in Q3 2024 to US$129.9 million in Q4 2024, then to...
NYSE:SYK
NYSE:SYKMedical Equipment

Stryker Balances Vascular Expansion With Cyberattack Securities Investigation Risks

Stryker (NYSE:SYK) has completed its acquisition of Amplitude Vascular Systems, adding new peripheral vascular technology focused on arterial disease. A law firm has launched a securities investigation into Stryker related to the March cyberattack and its reported impact on financial results. These developments come as Stryker continues recent M&A activity, following its Inari Medical deal, while also facing fresh legal and regulatory scrutiny. Stryker enters these headlines with shares at...
NasdaqGS:NWSA
NasdaqGS:NWSAMedia

News Corp (NWSA) Q2 EPS Holds 5.1% Margin Keeping Bullish Growth Narratives In Check

News Corp (NWSA) has just reported Q2 2026 results, with revenue of US$2.4b and basic EPS of US$0.34, while trailing 12 month revenue stands at US$8.6b and EPS at US$0.78, supported by net income from ongoing operations of US$193 million in the quarter and US$439 million over the last year. The company has seen quarterly revenue range from US$2.1b to US$2.4b over the last six reported periods, with basic EPS moving between roughly US$0.09 and US$0.40. This gives investors a clear read on how...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is Zscaler (ZS) Embedding Zero Trust in IoT SIMs to Deepen Its Platform Advantage?

In April 2026, IXT, a full MVNO specializing in secure IoT connectivity, announced it had integrated Zscaler’s Zero Trust Network Access into its SecureNet cellular platform at the SIM level, routing all device traffic through the Zscaler Zero Trust Exchange for inspection and policy enforcement. This move extends Zero Trust controls directly into global cellular infrastructure for high‑security, NIS2‑regulated industries, reducing reliance on VPNs and software agents for protecting widely...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom Faces OpenAI AI Chip Funding Test And Investor Valuation Questions

Broadcom (NasdaqGS:AVGO) is working on an estimated US$18b custom AI chip deal with OpenAI that now faces major financing challenges. Broadcom is seeking a commitment from Microsoft to purchase about 40% of the chips upfront before funding the initial phase of production. Uncertainty around Microsoft’s purchase commitment has contributed to delays in moving the project forward and volatility in Broadcom’s share price. Broadcom, through its semiconductor business, has been positioning its...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Assessing Arch Capital Group (ACGL) Valuation After Strong Q1 2026 Results And Completed Share Buyback

Why Arch Capital Group (ACGL) is back in focus Arch Capital Group (ACGL) has drawn fresh attention after its first quarter 2026 results showed net income of US$1,047 million and higher earnings per share, alongside a completed share repurchase that reduced the share count. See our latest analysis for Arch Capital Group. Despite the strong first quarter update and completed buyback, the share price has slipped over the past three months, with a 90 day share price return showing a 6.37%...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Is Down 17.1% After Raising 2026 Sales Outlook and Returning to Profitability - What's Changed

In early May 2026, Freshpet reported first-quarter net sales of US$297.64 million, a swing to net income of US$48.51 million and higher full-year 2026 net sales growth guidance to 8%–11%. Beyond the headline numbers, the return to profitability alongside raised sales expectations suggests that Freshpet’s operational changes and brand investments are starting to translate into financial progress. With Freshpet now profitable and lifting its 2026 sales outlook, we’ll examine how this improved...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

A Look At Exelon (EXC) Valuation After Recent Share Price Weakness

Why Exelon Stock Is Drawing Attention Now Exelon (EXC) has been on investors’ radar after recent share price moves, with the stock showing a 1-day return of 1.36% and a 9.46% decline over the past month. See our latest analysis for Exelon. Despite the recent 9.46% 1-month share price decline and a softer 7-day move, Exelon’s 1-year total shareholder return of 1.97% and 5-year total shareholder return of 65.72% suggest longer term holders have still seen positive results. This indicates...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies (HIMX) Is Up 36.4% After Q1 Beat And 100% Payout Dividend - Has The Bull Case Changed?

In early May 2026, Himax Technologies reported first-quarter 2026 results showing revenue of US$199.01 million and net income of US$7.99 million, alongside guidance for sequential revenue and earnings growth in the second quarter. The company also declared an annual cash dividend of US$0.252 per ADS, equal to a 100% payout of last year's profit, underscoring management’s confidence in its balance sheet and cash generation while it ramps automotive, AI, and optical technologies. We’ll now...
NYSE:TTAM
NYSE:TTAMBasic Materials

Weighing Titan America (TTAM) Valuation As Contrasting Fair Value Models Emerge

Recent performance snapshot for Titan America Titan America (TTAM) has drawn attention after recent share price swings, with a 1 day decline of 1.53%, a month gain of 11.82%, and a 10.24% decline over the past 3 months. See our latest analysis for Titan America. Short term momentum around Titan America's US$16.75 share price has been choppy, but the 1 year total shareholder return of 22.55% points to stronger performance over a longer horizon. If Titan America's recent swings have you...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept’s ALS Survival Signal Reframes Cortisol Modulation And Growth Outlook

Corcept Therapeutics reported long term survival data from its DAZALS Phase 2 trial of dazucorilant in ALS. Patients receiving 300 mg daily experienced an 87% reduction in risk of death at two years. The trial did not meet its primary functional endpoint, but the survival benefit attracted attention at the ENCALS 2025 meeting. For investors tracking NasdaqCM:CORT, this new ALS data adds another layer to the story around Corcept Therapeutics beyond its core cortisol modulation work. The...
NYSE:MMI
NYSE:MMIReal Estate

Is Marcus & Millichap (MMI) Turning Higher Revenue Into a More Resilient Investment Story?

Marcus & Millichap, Inc. recently reported first-quarter 2026 results, with revenue rising to US$171.47 million from US$145.04 million a year earlier and net loss narrowing to US$3.1 million from US$4.42 million. The combination of higher revenue and a smaller loss suggests early signs of operating improvement, even as the business remains in loss-making territory. We’ll now examine how this improved revenue performance and reduced loss shape Marcus & Millichap’s existing investment...
NasdaqCM:HYMC
NasdaqCM:HYMCMetals and Mining

A Look At Hycroft Mining (HYMC) Valuation After Wider Losses And Securities Law Investigation

Why Hycroft Mining Holding (HYMC) Is Back in Focus Hycroft Mining Holding (HYMC) has drawn fresh attention after reporting a wider first quarter net loss, alongside a securities law investigation examining potential false or misleading disclosures to investors. See our latest analysis for Hycroft Mining Holding. The stock has swung sharply over the past year, with a 59.34% year-to-date share price return and a very large 1-year total shareholder return, while the recent net loss and...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle (ORCL) Valuation Check After Strong Recent Share Price Momentum

Why Oracle Stock Is Back in Focus Oracle (ORCL) has drawn fresh attention after its recent share price moves, with the stock closing at $194.59 and posting double digit returns over the past month and past 3 months. See our latest analysis for Oracle. For context, the recent surge in Oracle's share price, including a 20.57% 7 day share price return and 35.92% 30 day share price return, sits alongside a 30.77% 1 year total shareholder return and triple digit 3 and 5 year total shareholder...
NYSE:KMPR
NYSE:KMPRInsurance

Assessing Kemper’s (KMPR) Valuation After A Year Of Sharp Share Price Weakness

Why Kemper Stock Is On Investors’ Radar Kemper (KMPR) has drawn attention after a stretch of weak share performance, with the stock down over the past day, week, month and past 3 months, and about 52% lower over the past year. For investors, that backdrop, alongside reported annual revenue of US$4,704.8 million and net income of US$41.9 million, raises practical questions about how to think about the company’s current valuation and risk profile. See our latest analysis for Kemper. Recent...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Is It Too Late To Consider Micron Technology (MU) After A 661% One Year Surge?

If you are wondering whether Micron Technology's share price still reflects fair value after a strong run, the key question is what the current market price is really paying for. The stock last closed at US$646.47, with returns of 25.0% over 7 days, 71.2% over 30 days, 105.0% year to date, and a very large 1 year gain of 661.0% that is roughly 7x. Recent headlines have focused on Micron Technology's position within the semiconductor industry and its role in supplying memory and storage for...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf (DBD) Valuation Check After VyStar Expansion And Return To Profitability

Diebold Nixdorf (DBD) is back on investors’ radar after VyStar Credit Union expanded its use of the company’s Branch Automation Solutions, alongside a recent first quarter update that showed revenue of US$891.8 million and net income of US$5 million. See our latest analysis for Diebold Nixdorf. The recent VyStar contract and first quarter update come after a strong run in the stock, with a 23.37% year to date share price return and a 70.17% total shareholder return over the past year,...
NasdaqGM:SOUN
NasdaqGM:SOUNSoftware

AI Small Caps Screened Three Quiet Engines Behind The Boom

AI is no longer just about the mega caps at the top of every headline. With central banks reacting to inflation, oil prices swinging on Middle East tensions, and trade patterns shifting from China to Europe and beyond, smaller AI focused stocks are where early product ideas, niche data tools, and automation platforms are being built. This AI Small Caps screener is designed to filter for those under the radar opportunities that sit inside these global cross currents. In this article, you will...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet Weighs Legal Settlements And Antitrust Risks Against Strong Share Gains

Alphabet (NasdaqGS:GOOGL) has agreed to settle a racial discrimination class-action lawsuit with Black employees, including commitments on pay equity reviews, greater pay transparency, and limits on mandatory arbitration. European Commission regulators have given Google extra time to respond to competition concerns, which may lead to regulatory action after the extended review. In the UK, Google faces a new lawsuit alleging abuse of dominance in display advertising, adding to its broader...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Raises US$400m As Alzheimer’s Collaboration Broadens Diagnostic Reach

Tempus AI (NasdaqGS:TEM) has completed an upsized US$400 million convertible note offering. The capital raise increases the company’s access to funding for acquisitions and investments. Shortly before the offering, Tempus AI expanded its collaboration with Quanterix/Lucent Diagnostics on Alzheimer’s disease blood tests. The Lucent Diagnostics partnership brings Tempus’ AI driven platform into neurological diagnostics alongside its existing oncology focus. For investors watching Tempus AI...